Atherosclerosis is the underlying cause of heart attack and stroke. Early observations that
cholesterol is a key component of arterial plaques gave rise to the cholesterol hypothesis for …

Chronic kidney disease (CKD) induces modifications in lipid and lipoprotein metabolism and
homeostasis. These modifications can promote, modulate and/or accelerate CKD and …

An increased risk of cardiovascular disease, independent of conventional risk factors, is
present even at minor levels of renal impairment and is highest in patients with end-stage …

Background and aim Previous studies showed that renal dysfunction was associated with
both a reduction in serum high-density lipoprotein (HDL) cholesterol concentration and …

More than half of all deaths among end stage renal disease (ESRD) patients are due to
cardiovascular disease (CVD). Cardiovascular changes secondary to renal dysfunction …

Plasma high density lipoprotein cholesterol (HDL) comprises a heterogeneous family of
lipoprotein species, differing in surface charge, size and lipid and protein compositions …

Results Patients with low HDL cholesterol and low eGFR had a higher burden of comorbid
illnesses. Over a median of 9.1 years (interquartile range, 7.7–9.4 years), 26,247 (40.1%) …

Rosenson et al Translation of HDL Function Into Clinical Practice 1257 divisions within this
density range have given rise to specific terminology for HDL subclasses. Pre-beta HDL …

Over the years, the relationship between high-density lipoprotein (HDL) and atherosclerosis,
initially highlighted by the Framingham study, has been revealed to be extremely complex …

Chronic kidney disease (CKD) is a worldwide health problem with steadily increasing
occurrence. Significantly elevated cardiovascular morbidity and mortality have been …